6-amino-penicillanic acid (6-APA)

6-amino-penicillanic acid (6-APA)
Product Description

Centrient Pharmaceuticals provides wide range of intermediates which includes 6-amino-penicillanic acid (6-apa). Characteristics: a crystalline powder manufactured by an enzymatic process starting from penicillin g potassium. Application: the product is used as an intermediate for the manufacture of semi-synthetic penicillins. Packaging & shipping: one polyethylene bag in a carton box l x w x h = 38 x 38 x 48 cm pallet loaded size l x w x h = 80 x 120 x 115 cm 12 boxes (2 layers of 6). Appearance: white to off-white crystalline powder. Contact us for more information.

Centrient Pharmaceuticals

  • NL
  • 2015
    On CPHI since
  • 3
    Certificates
  • 1000 - 4999
    Employees
Company types
Manufacturer/Innovator
Primary activities
Finished Formulation products Distributor/Buyer
Generic APIs producer
Specifications
  • Selling Points
    Packaging; Quality Service
  • Supplied from
    Netherlands
  • Measured In
    Kg

Centrient Pharmaceuticals

  • NL
  • 2015
    On CPHI since
  • 3
    Certificates
  • 1000 - 4999
    Employees
Company types
Manufacturer/Innovator
Primary activities
Finished Formulation products Distributor/Buyer
Generic APIs producer

More Products from Centrient Pharmaceuticals (29)

  • Amoxicillin

    Product Amoxicillin

    Centrient Pharmaceuticals provides wide range of drug products which includes amoxicillin. Dosage form: capsules; film-coated tablets; tablets; oral suspension; sachets. Contact us for more information.
  • 7-Aminodeacetoxy-cephalosporanic acid (7-ADCA)

    Product 7-Aminodeacetoxy-cephalosporanic acid (7-ADCA)

    7-Aminodeacetoxy-cephalosporanic acid (7-ADCA)
  • Amoxicillin +  Clavulanic acid

    Product Amoxicillin + Clavulanic acid

    Centrient Pharmaceuticals provides wide range of drug products which includes amoxicillin + clavulanic acid. Dosage form: film-coated tablets; oral suspension; sachets; injectables. Contact us for more information.
  • Amoxicillin
  • Atorvastatin

    Product Atorvastatin

    Centrient Pharmaceuticals provides wide range of drug products which includes atorvastatin. Dosage form: film-coated tablets. Contact us for more information.
  • Rosuvastatin

    Product Rosuvastatin

    Centrient Pharmaceuticals provides wide range of drug products which includes rosuvastatin. Dosage form: film-coated tablets. Contact us for more information.
  • 7-Aminodeacetoxy-cephalosporanic acid (7-ADCA)

    Product 7-Aminodeacetoxy-cephalosporanic acid (7-ADCA)

    Centrient Pharmaceuticals provides wide range of intermediates which includes 7-aminodeacetoxy-cephalosporanic acid (7-adca). Characteristics: a crystalline powder manufactured via a solvent free green route starting with fermentation followed by an enzymatic strep after which standard downstream processin...
  • Amoxicillin trihydrate compacted

    Product Amoxicillin trihydrate compacted

    Centrient Pharmaceuticals provides wide range of semi-synthetic penicillins which includes amoxicillin trihydrate compacted. Contact us for more information.
  • Amoxicillin trihydrate powder

    Product Amoxicillin trihydrate powder

    Centrient Pharmaceuticals provides wide range of semi-synthetic penicillins which includes amoxicillin trihydrate powder. Contact us for more information.
  • Ampicillin anhydrous compacted

    Product Ampicillin anhydrous compacted

    Centrient Pharmaceuticals provides wide range of semi-synthetic penicillins which includes ampicillin anhydrous compacted. Contact us for more information.
  • Ampicillin anhydrous powder

    Product Ampicillin anhydrous powder

    Centrient Pharmaceuticals provides wide range of semi-synthetic penicillins which includes ampicillin anhydrous powder. Contact us for more information.
  • Ampicillin trihydrate compacted

    Product Ampicillin trihydrate compacted

    Centrient Pharmaceuticals provides wide range of semi-synthetic penicillins which includes ampicillin trihydrate compacted. Contact us for more information.

Centrient Pharmaceuticals resources (8)

  • News Centrient Pharmaceuticals announces completion of acquisition of Astral SteriTech

    Centrient Pharmaceuticals (“Centrient”), the business-to-business leader in sustainable, enzymatic antibiotics, next-generation statins and anti-fungals, today announced the completion of the acquisition of Astral SteriTech Private Limited (“Astral SteriTech”).

    With the addition of Astral SteriTech’s Semi-Synthetic Cephalosporin and Semi-Synthetic Penicillin sterile injectable finished dosage forms to Centrient’s product portfolio, the company can now further meet the needs of customers and reach more patients with its critical life-saving medicine.

  • Brochure Finished Dosage Forms Portfolio

    Centrient Pharmaceuticals is a business-to-business provider of generics FDFs, not marketing the products ourselves. Therefore, we do not compete with our customers in the end market. All our dossiers are readily available for out-licensing to our partners worldwide. We work primarily with Europe-based FDFs manufacturers. Customers can be confident that the origin, traceability, and quality of our products are impeccable. We offer a dual sourcing strategy and procurement excellence for our third-party-produced APIs.
  • News Our PureActives® partnerships

    With our innovative enzymatic platform, we've been changing the game for sustainable antibiotics and statins production, step by step.
  • Brochure API Product Portflio

    We are a leading business-to-business provider of generic APIs. We help to secure patient safety, by driving Quality to the next level. Our reputation for producing high-quality generic APIs is well-known throughout the industry. Additionally, our business-to-business customers using our enzymatically produced APIs enjoy the freedom to operate, as these technologies are protected by patents.
  • News Centrient Pharmaceuticals to boost statins manufacturing capacity

    Doubling our API capacity to meet the growing demand
  • Technical Data Overview Available MAs

    Available Marketing Authorizations